全国服务咨询热线:

18438616290

Products产品中心
首页 > 产品中心 > 生化试剂 > 小分子化合物 > abs47028069Latanoprost 130209-82-4

Latanoprost 130209-82-4

简要描述:Latanoprost 130209-82-4
Latanoprost is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect.

  • 产品型号:abs47028069
  • 厂商性质:生产厂家
  • 更新时间:2026-01-15
  • 访  问  量:631

详细介绍

品牌absinCAS130209-82-4
分子式C26H40O5纯度>98%
分子量432.59货号abs47028069
规格2mg供货周期现货
主要用途is a prostaglandin F2alpha analogue应用领域化工,生物产业,农林牧渔,制药/生物制药,综合

Latanoprost  130209-82-4

产品描述
描述

Latanoprost is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect.

纯度
>98%
储存/保存方法
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
基本信息
别名
拉坦前列腺素;
外观
无色或微黄色油体
可溶性/溶解性
10 mM in DMSO
生物活性
靶点
Prostaglandin Receptor
In vitro(体外研究)
Benzalkonium chloride latanoprost (BAK-latanoprost) and 0.02% BAK induce significant apoptosis in the apical layers that correlated with the significant decrease of cell viability. Preservative-free latanoprost (PF-latanoprost) slightly decreases cell viability and few apoptotic cells are found in the superficial layers, without reaching statistical significance compared with PBS. Latanoprost (0.1 μM) significantly increases cell viability as compared with control. Meanwhile, 0.1 μM latanoprost results in the obvious promotion of neurite outgrowth similar to ciliary neurotrophic factor (CNTF) and simultaneously increases the levels of p-Akt and p-mTOR expression. Latanoprost can promote neurite outgrowth through an FP receptor-mediated modulation of the PI3K-Akt-mTOR signaling pathway. Latanoprost (0.03 or 0.3 μg/mL) and bimatoprost increase MMP-9 activity by 75% ± 27% and 75% ± 24%, respectively, in human CBSM cells.
In vivo(体内研究)
A single drop of latanoprost results in marked miosis, anterior bowing of the peripheral iris, narrowing of the iridocorneal angle, and shallowing of the anterior chamber of the beagle dog. Following latanoprost, the pupil diameter, ACA, and AOD (means) decreases 84%, 14%, and 16%, respectively.
参考文献
参考文献
  • 1. Patel SS and CM Spencer Latanoprost. Drugs Aging, 1996. 9(5): p. 363-78.

研究领域
研究领域
Drug DiscoverySmall Molecule DrugLead Compound Discovery
Latanoprost  130209-82-4温馨提示:本产品仅作科研实验使用,不支持临床等研究

产品咨询

留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7
爱必信(上海)生物科技有限公司
地址:上海市浦东新区新浩路58号申江科创园18栋
邮箱:lanwu@univ-bio.com
传真:
关注我们
欢迎您关注我们的微信公众号了解更多信息:
欢迎您关注我们的微信公众号
了解更多信息